Autism spectrum disorder
Conditions
Interventions
WMT treatment group:NA
Sponsors
The First Affiliated Hospital of Guangdong Pharmaceutical University
Eligibility
Sex/Gender
All
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: Autistic patients who have undergone at least two WMT treatments in the Department of Gastroenterology, the First Affiliated Hospital of Guangdong Pharmaceutical University. Inclusion Criteria: (1) Diagnosed with autism: meet the United States DSM-5 diagnostic criteria for autism; (2) Age at the time of signing the informed consent: 2-18 years old (excluding the cut-off value) autistic patients; (3) Gender: unlimited; (4) Inpatients in the Department of Gastroenterology, the First Affiliated Hospital of Guangzhou Pharmaceutical University, accompanied by a guardian; (5) Cooperate with bowel preparation; (6) The patient/family member agrees to participate in this trial and has signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Parents of children who are unable to cooperate with the relevant questionnaires and scales; (2) Patients undergoing other clinical studies at the same time; (3) Suffering from other brain diseases and abnormal judgment ability; (4) Patients with serious heart disease, liver disease, kidney disease and other major diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Childhood autism rating scale;Autism Behavior Checklist;25 hydroxyvitamin D; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep Disturbance Scale for Children;G-GIS;Bristol Stool Scale;Complete blood count;Liver function;Kidney function;Six trace elements;Serologic markers of the intestinal barrier;Gastric function;Infection four;Homocysteine; | — |
Countries
China
Contacts
Public ContactHe Xingxiang
The First Affiliated Hospital of Guangdong Pharmaceutical University
Outcome results
None listed